<![CDATA[Semaglutide could help prevent alcohol-use disorder]]>"Novo Nordisk's semaglutide has racked up several clinical wins demonstrating the GLP-1 receptor agonist's benefit goes beyond just weight loss, with the most recent data showing the drug can reduce mortality in patients with type 2 diabetes and chronic kidney disease, while earlier findings cemented its ability to reduce major adverse cardiovascular events.

Now, a new study suggests it may be able to help people who suffer from alcohol-use disorder (AUD)".

Read more: https://firstwordpharma.com/story/5861815

120676_fullsizeoutput_245b.jpeg

]]>https://dev.proinvestor.com/forum/topic/446522/semaglutide-could-help-prevent-alcohol-use-disorderRSS for NodeThu, 18 Jun 2026 21:23:19 GMTThu, 30 May 2024 03:18:58 GMT60<![CDATA[Reply to Semaglutide could help prevent alcohol-use disorder on Thu, 30 May 2024 09:24:43 GMT]]>Det gør det hvis man har købt aktien 🙂

]]>https://dev.proinvestor.com/forum/post/9488665https://dev.proinvestor.com/forum/post/9488665Thu, 30 May 2024 09:24:43 GMT<![CDATA[Reply to Semaglutide could help prevent alcohol-use disorder on Thu, 30 May 2024 04:10:01 GMT]]>Det kan jo kurere alt. Håber det også virker mod lommesmerter!

]]>https://dev.proinvestor.com/forum/post/9488673https://dev.proinvestor.com/forum/post/9488673Thu, 30 May 2024 04:10:01 GMT